A program that supports historically disadvantaged health professionals chooses two researchers in the UAB Department of Medicine as finalists.
A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.
Knowledge from this study and others may help physicians boost healing and prevent heart failure in patients after a heart attack.
These leaders represent the next generation of cardiologists who are working to educate their colleagues, conduct research on new and novel strategies to advance cardiovascular care, and innovate the unique aspects of the cardiology specialty. 
Twelve School of Medicine faculty were recently honored as winners of the UAB Graduate Dean's Excellence in Mentorship Award.
The grant will initially fund two fellowship positions for postdoctoral fellows (basic or clinical) wishing to train in the area of heart failure research.
A heart attack can happen even if to those who are relatively young and fit, and genetics can play a role.
The findings suggest targeting specific T-cell subsets may be a therapeutic approach to prevent heart failure after a heart attack.
Some people inherit a condition that elevates their cholesterol to an excessive degree, and no amount of diet or exercise can bring the numbers down. UAB researchers are developing and testing a new peptide that may lead to better treatment options.
James Ward could not walk from his office to his car without having trouble breathing until a life-changing heart pump gave him hope.
Page 1 of 6